Vivos Inc.
RDGL
Rank in Stocks
#26171
Vivos Inc. is a medical technology company focused on radiation oncology,... Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Share Price
$0.044
Last synced: 2026-11-09
Market Cap
$21.75M
Change (1 day)
0.00%
Change (1 year)
-52.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vivos Inc. (RDGL)
Category
Healthcare
Operating Margin for Vivos Inc. (RDGL)
Operating Margin as of November 2026 TTM: -2,852.46%
According to Vivos Inc.'s latest financial reports, its current operating margin (TTM) is -2,852.46%. At the end of 2025 the company had an operating margin of -4,628.68%.
Operating Margin history for Vivos Inc. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2,852.46% | -38.37% |
| 2025 | -4,628.68% | -50.24% |
| 2024 | -9,301.66% | -35.06% |
| 2023 | -14,323.08% | 107.62% |
| 2022 | -6,898.82% | -58.95% |
| 2021 | -16,806.61% | 74.81% |
| 2020 | -9,614.29% | -31.33% |
| 2019 | -14,000.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | -64,553.53% | 17.99% |
| 2016 | -54,711.40% | 546.24% |
| 2015 | -8,466.07% | 4.40% |
| 2014 | -8,109.34% | 218.49% |
| 2013 | -2,546.18% | 7.54% |
| 2012 | -2,367.64% | 263.74% |
| 2011 | -650.91% | -36.99% |
| 2010 | -1,032.96% | 29.77% |
| 2009 | -795.97% | -64.05% |
| 2008 | -2,214.05% | 11.18% |
| 2007 | -1,991.47% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.01% |
US
|
|
| 18.08% | -100.01% |
IE
|
|
| 21.25% | -100.01% |
US
|
|
| 21.05% | -100.01% |
US
|
|
| 28.09% | -100.01% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Vivos Inc.'s operating margin
What is Vivos Inc.'s operating margin?
Vivos Inc.'s operating margin is -2,852.46%, as of Nov 2026.
What was Vivos Inc.'s operating margin in 2025?
In 2025, Vivos Inc.'s operating margin was -4,628.68%, compared with -9,301.66% in 2024.
How has Vivos Inc.'s operating margin changed since 2020?
From 2020 to 2025, Vivos Inc.'s operating margin was highest in 2025 (-4,628.68%) and lowest in 2021 (-16,806.61%).
How does Vivos Inc.'s operating margin compare with similar companies?
Vivos Inc.'s operating margin (-2,852.46%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.